Browsing by Sponsor/Funder St Stephen's Aids Trust

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 3 to 19 of 19 < previous 
Issue DateTitleAuthor(s)
1-Aug-2015Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in ChinaChen, Y; Li, N; Zhang, T; Huang, X; Cai, F, et al
-Development of a Sensitive, Quantitative Assay with Broad Subtype Specificity for Detection of Total HIV-1 Nucleic Acids in Plasma and PBMCKibirige, C; Manak, M; King, D; Abel, B; Hack, H, et al
27-Jun-2017Enrichment of HLA types and single-nucleotide polymorphism associated with non-progression in a strictly defined cohort of HIV-1 controllersWestrop, SJ; Cocker, ATH; Boasso, A; Sullivan, AK; Nelson, MR, et al
1-Jun-2018Functional immune characterization of HIV-associated non-small-cell lung cancerPinato, DJ; Kythreotou, A; Mauri, FA; Suardi, E; Allara, E, et al
15-Mar-2016Gag- and Nef-specific responses are associated with increased proportions of regulatory T cells in treated chronic HIV-1 infectionCocker, A; Hardy, G; Herasimtschuk, A; Imami, N; Nelson, M, et al
4-Apr-2017HIV-1-positive pregnancies demonstrate altered IFN gamma and IL-10 responses to flu and CMV and disrupted DC, NK and T-cell profilesCocker, A; Imami, N; Johnson, M; Dermont, S; Khan, W, et al
Nov-2018Inhibiting growth of clostridioides difficile by restoring valerate, produced by the intestinal microbiotaMcDonald, JAK; Mullish, BH; Pechlivanis, A; Liu, Z; Brignardello, J, et al
5-Jun-2015Multifarious immunotherapeutic approaches to cure HIV-1 infectionImami, N; Herasimtschuk, AA; , et al
Apr-2019Pharmacological impact of antiretroviral therapy on platelet function to investigate HIV-associated cardiovascular riskTaylor, KA; Smyth, E; Rauzi, F; Cerrone, M; Khawaja, AA, et al
11-Feb-2020Pregnancy gestation impacts on HIV-1-specific granzyme B response and central memory CD4 T cellsCocker, A; Shah, N; Raj, I; Dermont, S; Khan, W, et al
14-Aug-2017Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: a pilot studyMletzko, S; Pinato, DJ; Robey, RC; Pria, AD; Benson, P, et al
22-Jun-2018PROX1 is a transcriptional regulator of MMP14Gramolelli, S; Cheng, J; Martinez-Corral, I; Vähä-Koskela, M; Elbasani, E, et al
17-Jun-2017PWE-093 Development and validation of an automated system for assessment of liver steatosis and fibrosis in routine: histological images in patients with non-alcoholic fatty liver diseaseForlano, R; Mullish, BH; Maurice, J; Angkathunyakul, N; Goldin, E, et al
13-Apr-2017Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patientsDalla Pria, A; Pinato, D; Roe, J; Naresh, K; Nelson, M, et al
16-Oct-2017The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinomaPinato, DJ; Sharma, R; Citti, C; Platt, H; Ventura-Cots, M, et al
5-Mar-2019Therapeutic immunisation benefits mucosal-associated invariant T-cell recovery in contrast to IL-2, GM-CSF, and rhGH addition in HIV-1+ treated patients: individual case reports from phase I trialCocker, ATH; Greathead, L; Herasimtschuk, AA; Mandalia, S; Kelleher, P, et al
24-Jan-2018Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycinMacIntyre, DA; Brown, R; Marchesi, J; Lee, Y; Smith, A, et al